On The Pen With Dave Knapp

Dave Knapp Man On The Mounjaro, Bleav
  • 4.9(181개의 평가)
  • 의학
  • 매주 업데이트
On The Pen With Dave Knapp

Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

  1. 2일 전

    Generic Liraglutide and GLP-1 Accessibility

    Dave brings you up to speed on the latest on accessibility to Zepbound, Mounjaro, Ozempic and Liraglutide

    24분

  2. 2024. 12. 30.

    More Generic GLP-1 Options Hit The Market!

    Send us a textIn this special Christmas Eve Eve episode of On The Pen: The Weekly Dose, host Dave Knapp dives into groundbreaking updates in GLP-1 medication news, including terzepatide's FDA recognition for resolving obstructive sleep apnea, which could revolutionize insurance coverage for Zepbound. The podcast covers expanded access to generic liraglutide, highlighting its affordability and potential impact on maintenance therapy for obesity and diabetes. Dave also discusses Eli Lilly’s vic...

    41분

  3. 2024. 12. 17.

    On The Pen: The Weekly Dose 12.17.24

    Send us a textBuy The BooK!https://amzn.to/3Bzs4Ggro.co/OTPSupport the showOur Book Has Been Released!Decoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/chan...

    26분

  4. 2024. 12. 16.

    An Inflatable Stomach Balloon for Weight Loss

    Send us a textIn this special episode of the On The Pen Podcast, I sit down with Shantanu Gaur, the visionary CEO and co-founder of Allurion, to dive deep into the science and innovation behind the Allurion Balloon—a non-surgical, FDA-approved weight loss solution that’s transforming the way we approach obesity treatment.We discuss the technology behind this swallowable gastric balloon, its role in reducing food intake and promoting sustainable weight loss, and how Allurion combines cutting-e...

    57분

  5. 2024. 12. 14.

    A GLP-1 Monopoly In The Making: Biden Admin Fails to Act, Novo Acquires Catalent

    Send us a texthttps://www.onthepen.com/post/novo-nordisk-catalent-deal-approvedSupport the showOur Book Has Been Released!Decoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://...

    10분

  6. 2024. 12. 11.

    OFA Representation in Compound Tirzepatide Case Sits Down with OTP

    Send us a textSupport the showOur Book Has Been Released!Decoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join👉 My Amazon ...

    19분

  7. 2024. 12. 11.

    CagriSema Delay? Novo Catalent Update

    Send us a textSupport the showOur Book Has Been Released!Decoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join👉 My Amazon ...

    22분

  8. 2024. 12. 03.

    American Diabetes Association on the Wrong Side of Compounded GLP-1 Meds

    Send us a texthttps://diabetes.org/newsroom/press-releases/american-diabetes-association-announces-statement-compounded-incretinSupport the showOur Book Has Been Released!Decoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnTheP...

    21분
모두 보기(80개)

4.9
최고 5점
181개의 평가

소개

Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

정보

  • 제작진
    Dave Knapp Man On The Mounjaro, Bleav
  • 방송 연도
    2024년 - 2025년
  • 에피소드
    80
  • 등급
    전체 연령 사용가
  • 저작권
    © 2025 On The Pen With Dave Knapp
  • 웹사이트 보기
    On The Pen With Dave Knapp

좋아할 만한 다른 항목

무삭제판 에피소드를 청취하려면 로그인하십시오.

이 프로그램의 최신 정보 받기

프로그램을 팔로우하고, 에피소드를 저장하고, 최신 소식을 받아보려면 로그인하거나 가입하십시오.
국가 또는 지역 선택

아프리카, 중동 및 인도

아시아 태평양

유럽

라틴 아메리카 및 카리브해

미국 및 캐나다